Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

NCT05304481 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: ATL administration

Sponsor

Lukas Biomedical Inc.

Collaborators

[object Object]